Fatal infectious mononucleosis with evidence suggestive of the development of B cell lymphoma

Pathology International

Volumn 53, Issue 9, 2003, Pages 642-648

  Hiroshima, Kenzo ^a,b   Iyoda, Akira ^a   Isobe, Kouichi ^a   Ishii, Genichiro ^b   Toyozaki, Tetsuya ^a   Shibuya, Kiyoshi ^a   Shimamura, Fumihiko ^a   Haga, Yukiko ^a   Okimoto, Yuri ^a   Horie, Hiroshi ^c   Harigaya, Kenichi ^b   Ohwada, Hidemi ^a  

^a Department of Basic Pathology ^*  (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

Author keywords

Epstein barr virus; Hemophagocytic syndrome; Infectious mononucleosis; Lymphoma; Lymphoproliferative disorders

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN A; ETOPOSIDE; PREDNISOLONE;

ARTICLE; AUTOPSY; B CELL LYMPHOMA; BONE MARROW; CASE REPORT; CELL PROLIFERATION; DEATH; EPSTEIN BARR VIRUS; ERYTHROPHAGOCYTOSIS; FEMALE; HISTIOCYTE; HUMAN; INFECTIOUS MONONUCLEOSIS; LIVER; LUNG; LYMPH NODE; PRESCHOOL CHILD; PRIORITY JOURNAL; SPLEEN; THYMUS; TONSIL DISEASE; TONSILLECTOMY; VIRUS INFECTION;

ADENOIDECTOMY; CHILD, PRESCHOOL; DNA, NEOPLASM; FATAL OUTCOME; FEMALE; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; GLUCOCORTICOIDS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFECTIOUS MONONUCLEOSIS; LYMPHOMA, B-CELL; POLYMERASE CHAIN REACTION; TONSILLECTOMY;

EID: 10744227978     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01522.x     Document Type: Article

References (34)

1. De Waele M, Thielemans C, Van Camp BK. Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies. N Engl J Med 1981; 304: 460-62.
2. Thorley-Lawson DA. Immunological responses to Epstein-Barr virus infection and the pathogenesis of EBV-induced diseases. Biochim Biophys Acta 1988; 948: 263-86.
3. Reinherz EL, O'Brien C, Rosenthal P, Schlossman SF. The cellular basis for viral-induced immunodeficiency: analysis by monoclonal antibodies. J Immunol 1980; 125: 1269-74.
4. Risdall RJ, McKenna RW, Nesbit ME et al. Virus-associated hemophagocytic syndrome - A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 1979; 44: 993-1002.
5. Chen RL, Su IJ, Lin KH et al. Fulminant childhood hemophagocytic medullary reticulosis. Am J Clin Pathol 1991; 96: 171-6.
6. Henter JI, Elinder G, Soder O, Hansson M, Andersson B, Andersson U. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood 1991; 78: 2918-22.
7. Foss HD, Herbst H, Hummel M et al. Pattern of cytokine gene expression in infectious mononucleosis. Blood 1994; 83: 707-12.
8. Imashuku S, Hibi S, Fujiwara F, Ikushima S, Toso S. Haemophagocytotic lymphohistiocytosis, interferon-gamma-naemia and Epstein-Barr virus involvement. Br J Haematol 1994; 88: 656-8.
9. Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 1997; 100: 1969-79.
10. Hiroshima K, Toyozaki T, Iyoda A, Yusa T, Fujisawa T, Ohwada H. Apoptosis and proliferative activity in mature and immature teratomas of the mediastinum. Cancer 2001; 92: 1798-806.
11. Tamaru J, Hummel M, Zemlin M, Kalvelage B, Stein H. Hodgkin's disease with a B-cell phenotype often shows a VDJ rearrangement and somatic mutations in the VH genes. Blood 1994; 84: 708-15.
12. Penman HG. Fatal infectious mononucleosis: a critical review. J Clin Pathol 1970; 23: 765-71.
13. Nuckols JD, Baron PW, Stenzel TT et al. The pathology of liver-localized post-transplant lymphoproliferative disease: a report of three cases and a review of the literature. Am J Surg Pathol 2000; 24: 733-41.
14. Imashuku S, Kuriyama K, Teramura T et al. Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Clin Oncol 2001; 19: 2665-73.
15. McCarthy M. Gene mutation responsible for fatal EBV complication discovered. Lancet 1998; 352: 1125.
16. Allen M, De Fusco C, Legrand F et al. Familial hemophagocytic lymphohistiocytosis: how late can the onset be? Haematologica 2001; 86: 499-503.
17. Arico M, Danesino C, Pende D, Moretta L. Pathogenesis of haemophagocytic lymphohistiocytosis. Br J Haematol 2001; 114: 761-9.
18. Henter JI, Elinder G, Ost A. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol 1991; 18: 29-33.
19. Arico M, Allen M, Brusa S et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br J Haematol 2002; 119: 180-88.
20. Rickinson AB. Chronic, symptomatic Epstein-Barr virus infections. Immunol Today 1986; 7: 13-14.
21. Straus SE. The chronic mononucleosis syndrome. J Infect Dis 1988; 157: 405-12.
22. Tobi M, Morag A, Ravid Z et al. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet 1982; 1: 61-4.
23. Wick MJ, Woronzoff-Dashkoff KP, McGlennen RC. The molecular characterization of fatal infectious mononucleosis. Am J Clin Pathol 2002; 117: 582-8.
24. Purtilo DT, Strobach RS, Okano M, Davis JR. Epstein-Barr virus-associated lymphoproliferative disorders. Lab Invest 1992; 67: 5-23.
25. Teruya-Feldstein J, Jaffe ES, Burd PR et al. The role of Mig, the monokine induced by interferon-gamma, and IP-10, the interferon-gamma-inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997; 90: 4099-105.
26. Miller DJ, Dwyer JM, Klatskin G. T-cells and the hepatitis of infectious mononucleosis. N Engl J Med 1976; 295: 450.
27. Tazawa Y, Nishinomiya F, Noguchi H et al. A case of fatal infectious mononucleosis presenting with fulminant hepatic failure associated with an extensive CD8-positive lymphocyte infiltration in the liver. Hum Pathol 1993; 24: 1135-9.
28. Dolezal MV, Kamel OW, van de Rijn M, Cleary ML, Sibley RK, Warnke RA. Virus-associated hemophagocytic syndrome characterized by clonal Epstein-Barr virus genome. Am J Clin Pathol 1995; 103: 189-94.
29. Markin RS, Linder J, Zuerlein K et al. Hepatitis in fatal infectious mononucleosis. Gastroenterology 1987; 93: 1210-17.
30. Yatabe Y, Mori N, Oka K et al. Fatal Epstein-Barr virus-associated lymphoproliferative disorder in childhood. Arch Pathol Lab Med 1995; 119: 409-17.
31. Gaffey MJ, Frierson HF Jr,, Medeiros LJ, Weiss LM. The relationship of Epstein-Barr virus to infection-related (sporadic) and familial hemophagocytic syndrome and secondary (lymphoma-related) hemophagocytosis: an in situ hybridization study. Hum Pathol 1993; 24: 657-67.
32. Ohshima K, Kikuchi M, Eguchi F, Kobari S, Tasaka H. Virus-associated haemophagocytic syndrome with Epstein-Barr virus infection. Virchows Arch A Pathol Anat Histopathol 1991; 419: 519-22.
33. Kerr BM, Lear AL, Rowe M et al. Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology 1992; 187: 189-201.
34. Xu ZG, Iwatsuki K, Oyama N et al. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas. Br J Cancer 2001; 84: 920-25.